- RecruitingPHASE3
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
This study compares a new treatment called IMA203 with standard care for advanced skin melanoma that has already been treated. Its main goal is to see if IMA203 is more effective and safe for patients who have limited treatment options.
For: Melanoma, Cutaneous MalignantUnited States · Canada · France - Active not recruitingPHASE2
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
This study is testing a new treatment called lifileucel for advanced melanoma, a type of skin cancer. It's for adults whose cancer has continued to grow despite previous treatments. The aim is to see if lifileucel can help control the cancer.
For: Melanoma (Skin Cancer) · Unresectable Melanoma · Metastatic MelanomaUnited States · Australia · Canada